DHRM [Lianluo Smart] 6-K: (Original Filing)
[]
[Resolutions of the Annual General Meeting of Members TAINAN, Taiwan – August 26, 2020 th 1. Shareholder(s) Adoption of the Company’s 2019 Audited Accounts and Financial Reports 2. Retirement and Re-election of Mr. Hsiung-Ku Chen as an Independent Director of the Company] [Form 6-K 000-51847 Himax Te]
[Resolutions of the Annual General Meeting of Members TAINAN, Taiwan – August 26, 2020 th 1. Shareholder(s) Adoption of the Company’s 2019 Audited Accounts and Financial Reports 2. Retirement and Re-election of Mr. Hsiung-Ku Chen as an Independent Director of the Company] [Form 6-K 000-51847 Himax Te]
[Our ref VSL/653749-000010/18182312v1 Direct tel Email 21Vianet Group, Inc. Guanjie Building Southeast 1st Floor 10# Jiuxianqiao East Road Chaoyang District Beijing, 100016 Peoples Republic of China 25 August Dear Sirs 21Vianet Group, Inc. We have acted as Cayman Islands legal advisers to Company Re]
[Our ref VSL/653749-000010/18182312v1 Direct tel Email 21Vianet Group, Inc. Guanjie Building Southeast 1st Floor 10# Jiuxianqiao East Road Chaoyang District Beijing, 100016 Peoples Republic of China 25 August Dear Sirs 21Vianet Group, Inc. We have acted as Cayman Islands legal advisers to Company Re]
[Use these links to rapidly review the document Title of each class of securities Amount to be Proposed maximum Proposed maximum Amount of Class A ordinary shares, par value US$0.00001 per share 117,300,000 US$3.46 US$405,662,500 US$52,655 (1) (2) (3) Prospectus Supplement 17,000,000 American Deposit]
[Use these links to rapidly review the document Title of each class of securities Amount to be Proposed maximum Proposed maximum Amount of Class A ordinary shares, par value US$0.00001 per share 117,300,000 US$3.46 US$405,662,500 US$52,655 (1) (2) (3) Prospectus Supplement 17,000,000 American Deposit]
[Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation BEIJING, China – August 25, 2020 -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has signed two agreements in Hainan, Ch]
[Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation BEIJING, China – August 25, 2020 -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has signed two agreements in Hainan, Ch]